Accès ouvert
2019
article
OpenAlex
Earl Randy Craven, Thomas R. Walters, William C. Christie, Douglas G. Day et autres
OBJECTIVE: The objective of this study was to evaluate the safety and intraocular pressure (IOP)-lowering effects over 24 months of biodegradable bimatoprost sustained-release implant (Bimatoprost SR) administration versus topical bimatoprost 0.03% in patients with open-angle glaucoma (OAG). METHODS: This was a phase …
us
(code pays fourni par la source)
Accès ouvert
2019
article
OpenAlex
Sanjay Asrani, Alan Lee Robin, Janet B. Serle, Richard Alan Lewis et autres
PURPOSE: To compare the ocular hypotensive efficacy and safety of a fixed-dose combination (FDC) of the Rho kinase inhibitor netarsudil and latanoprost vs monotherapy with netarsudil or latanoprost. DESIGN: Three-month primary endpoint analysis of a randomized, double-masked, phase 3 clinical trial. METHODS: …
us
(code pays fourni par la source)
Accès ouvert
2016
article
OpenAlex
Richard Alan Lewis, William C. Christie, Marina Bejanian, Susan S. Lee et autres
PURPOSE: To evaluate the safety and intraocular pressure (IOP)-lowering effect of a biodegradable bimatoprost sustained-release implant (Bimatoprost SR). DESIGN: Phase I/II, prospective, 24-month, dose-ranging, paired-eye controlled clinical trial. METHODS: At baseline following washout, open-angle glaucoma patients (n = 75) were administered Bimatoprost …
us, sa
(code pays fourni par la source)
2004
article
OpenAlex
Mary Jo Stiegemeier, Ronald Cedrone, David Evans, Greg Friederichs et autres
us
(code pays fourni par la source)
1999
article
OpenAlex
Howard I. Schenker, Susan A. Maloney, Charles L. Liss, Glenn J. Gormley et autres
us
(code pays fourni par la source)
1980
article
OpenAlex
Maurice H. Luntz, Howard I. Schenker
us
(code pays fourni par la source)
1980
article
OpenAlex
Howard I. Schenker, Maurice H. Luntz, Barry D. Kels, Steven M. Podos
us
(code pays fourni par la source)